Insurance coverage for tirzepatide is fragmented across commercial insurance, Medicare, and Medicaid. Coverage decisions depend heavily on whether the prescription is for type 2 diabetes (Mounjaro, often covered) or chronic weight management (Zepbound, less commonly covered).
For type 2 diabetes, Mounjaro is widely covered by commercial insurance plans, often with prior authorization. For chronic weight management, Zepbound coverage is much more variable — many commercial plans exclude weight-loss medications. Medicare Part D does not cover medications used for weight loss alone but may cover Mounjaro for diabetes. Medicaid coverage varies by state. Compounded tirzepatide is generally not covered by any insurance.
NexLife is structured around clinical best practices for tirzepatide. The same flat-rate pricing applies across the entire titration schedule ($186/mo on the 12-month plan from 2.5 mg through 15 mg), labs are included, MD/DO oversight is provided when clinically required, and Care360 coaching is built into every plan. See full NexLife review.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000